Ask AI

Patient Voices, Expert Guidance: Personalizing Treatment of Early Breast Cancer in Patients at Risk of Health Disparities and Common Comorbidities

Gain expert insights into treatment strategies for patients with early breast cancer based on emerging evidence for (neo)adjuvant treatments to improve outcomes through medical minute text-based activity and downloadable slides, certified ClinicalThought commentaries, an Interactive Decision Support Tool, and a podcast.

Share

Program Content

Activities

Optimizing Outcomes in EBC
Optimizing Outcomes in Early Breast Cancers: A Call To Action
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: March 12, 2026

Expires: September 11, 2026

Activities

HER2 Positive EBC
Evolving Treatment Landscape for HER2-Positive/HER2-Low Early Breast Cancer
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: May 01, 2026

Expires: October 31, 2026

HR Positive HER2 Negative EBC
Evolving Treatment Landscape for High-Risk HR-Positive/HER2-Negative EBC With and Without gBRCAm
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: May 21, 2026

Expires: November 20, 2026

Activities

HER2+ EBC
Evolving Treatment Landscape for HER2-Positive Early Breast Cancer
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: April 29, 2026

Expires: October 28, 2026

HR-Positive/HER2-Negative EBC
High-Risk HR-Positive/HER2-Negative EBC With and Without gBRCAm
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: May 26, 2026

Expires: November 25, 2026

Activities

Patient Voices Early Breast Cancer
Patient Voices: Caring for the Whole Patient and Personalizing Treatment of Early Breast Cancer to Achieve Equitable Outcomes
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: April 15, 2026

Expires: October 14, 2026

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC dba Decera Clinical Education in partnership with Tigerlily Foundation.

Supporters

Supported by educational grants from AstraZeneca and Daiichi Sankyo, Inc.

AstraZeneca

Daiichi Sankyo, Inc.

Partners

Tigerlily Foundation

ProCE Banner